ARCHIVES

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: JNCI Article Describes Advances Pancreatic Cancer; Preventative Oncology Society Formed

August 13, 1976

Obituary: Emmanuel Farber, Experimental Pathologist, Dies at Age 95

August 8, 2014

Laertrile Clinical Study Provides Solid Evidence: It Is Useless

May 8, 1981

NCI Cooperative Group, Cancer Center Trials Listed

December 26, 2008

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

February 7, 1997